|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Kura Oncology (NASDAQ: KURA) through any online brokerage.
The latest price target for Kura Oncology (NASDAQ: KURA) was reported by Credit Suisse on November 26, 2021. The analyst firm set a price target for 21.00 expecting KURA to rise to within 12 months (a possible 55.33% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Kura Oncology (NASDAQ: KURA) is $13.52 last updated Thu Dec 02 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Kura Oncology.
Kura Oncology’s $Q4 earnings are confirmed for after-market on February 23, 2022.
There is no upcoming split for Kura Oncology.
Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.